Court authorizes class action over antipsychotic drug that allegedly causes compulsive behaviour
The Superior Court of Quebec has authorized a national class action against pharmaceutical companies Otsuka Canada and Lundbeck Canada over allegations that their antipsychotic drug Rexulti causes compulsive behaviors, according to...To view the full article, register now.
Already a subscriber? Click here to view full article